Best Biopharma Outsourcing Companies in Ontario, Canada
The 86 best Biopharma Outsourcing companies in Ontario, Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: AtomVie.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Ontario
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AtomVie Provider of diversified CDMO services for radiotherapeutics | $90M | 36 mo ago | Series A | — | 2021 | WordPressApple iCloud MailMicrosoft 365+19 | — | 5 job openings · 1 expansion |
| 2 | Therapure Biopharma Contract development and manufacturing organization that specializes in the development, manufacture of… | $24M | 129 mo ago | Funding Raised | — | 2008 | — | 52 patents Hemoglobin-targeted drug carriers and large‑scale protein/albumin purification technologies | — |
| 3 | High Q Technologies Developer of quantum-enabled electron paramagnetic resonance systems for protein analysis | $10M | 27 mo ago | Seed | Wendy Hinchey CEO | 2013 | — | — | 1 job opening · 1 partnership |
| 4 | Contract Pharmaceuticals CDMO focused on manufacturing of semi-solid pharmaceutical drugs | $9M | 132 mo ago | Acquired | Ken Paige CEO | 1991 | WordPressMySQLPHP+19 | 38 patents Pharmaceutical dosage packaging, consumable storage vessels, and pyrethroid spray formulation technologies. | — |
| 5 | CryoStasis Developer of subzero unfrozen cell preservation platform for cell and gene therapy | $8M | 34 mo ago | Seed | — | 2022 | — | 10 patents Cryogenic preservation and storage systems for biological specimens and tissues | — |
| 6 | Biomind Labs Developer of novel pharmaceuticals targeting neurological disorders and related conditions | $6M | 56 mo ago | Public | — | 2005 | — | 9 patents Patents concentrated in chemistry & materials | — |
| 7 | CEN Biotech Holding company focused on hemp based healthcare services & products | $3M | 122 mo ago | Seed | Joseph Byrne CEO | 2013 | — | — | — |
| 8 | Liberum Provider of protein synthesizers manufacturing, pre-clinical research, and drug development services among… | $2M | 35 mo ago | Seed | — | 2019 | — | — | — |
| 9 | Quality Green Provider of medical cannabis | $2M | 90 mo ago | Deadpooled | Andrew Spasiw CEO | 2015 | — | — | — |
Top 12 Biopharma Outsourcing companies in Ontario
#1
Seed · Waterloo, Ontario · founded 2013 · 24 employees$10.2Mraised▾
Developer of quantum-enabled electron paramagnetic resonance systems for protein analysis. The company’s systems resolve complex problems in protein dynamics for drug discovery. It offers a sample measurement service to provide researchers with insights into molecular dynamics. The organization’s technology aims to redefine standards in protein structure determination.
- Feb 2024Seed$3.8M
- 2019Seed$6.5M
#2
Series A · Hamilton, Ontario · founded 2021 · 92 employees$90Mraised▾
Provider of diversified CDMO services for radiotherapeutics
- Jun 2023Series A—
- Aug 2022Series A$90M
#3
Seed · Ottawa, Ontario · founded 2022 · 8 employees$8Mraised▾
Developer of subzero unfrozen cell preservation platform for cell and gene therapy. The company’s platform uses media, temperature, and pressure to preserve biological material. The media formulation leverages cold shock inhibitors and membrane protectants. Temperature systems include devices and shipping solutions. Pressure systems lower the freezing point and cell metabolism, enabling long-term storage.
- Jul 2023Seed$8M
#4
Seed · Toronto, Ontario · founded 2019 · 3 employees$2Mraised▾
Developer of a biotechnology platform intended to democratize access to the fruits of synthetic biology. The company's platform uses proprietary molecular and hardware technology, protein synthesizers help to speed up the production of enzymes, therapeutics, and lab reagents, enabling clients to bring speed, scalability, and reduce cost.
- Jul 2023Seed$1.8M
- Jun 2020Seed$250K
#5
Public · Toronto, Ontario · founded 2005 · 5 employees$6Mraised▾
Developer of novel pharmaceuticals targeting neurological disorders and related conditions. The company focuses on transforming biomedical sciences knowledge into fast-acting and controlled-release drugs. Tailored drug delivery systems target specific therapeutic indications beyond mental health. Research and development aims to change lives by providing safe and efficient pharmaceuticals. The company adheres to strict scientific standards to protect patients and ensure reliable clinical trial results.
- Sep 2021Post IPO$6M
#6
Funding Raised · Mississauga, Ontario · founded 2008 · 225 employees$24.2Mraised▾
Therapure Biopharma focuses on manufacturing complex biologics and on developing, manufacturing, and selling its blood and plasma-related therapeutic products. It operates through three divisions: Therapure Biomanufacturing (Mammalian cell line based CDMO), Therapure Biologics (Plasma-derived products), and Therapure Innovations (Proprietary drug development). It provides contract development and manufacturing services for integrated biologics and also offers drug discovery, research, and development services. The company also focuses on the development of a portfolio of its own plasma-derived protein therapeutics through its technology, PlasmaCap EBA (for efficient capture of plasma proteins at high yields and purities). Therapure Innovations' lead candidates TBI 302 (liver cancer) and TBI 304H (anemia) are undergoing phase I trials while TBI 301 (Hep C) is in the discovery stage. The company is funded by the Catalyst Capital Group since its inception. The company's CDMO business and certain rights to their plasma products and technology for the Chinese market were acquired by a JV between 3SBio and CPE funds.
- Aug 2015Conventional Debt$20M
- Apr 2010Grant (prize money)$4.2M
#7
Acquired · Mississauga, Ontario · founded 1991 · 325 employees$9Mraised▾
Operator of contract development and manufacturing organization intended to focus on pharmaceuticals. The company offers the making, packaging and testing of non-sterile liquid and semi-solid pharmaceutical and regulated over-the-counter products including lotions, creams, solutions, nasal sprays and gels, enabling clients to get efficient and cost-effective items made with mixing capabilities.
- May 2015Grant (prize money)$9M
#8
Deadpooled · Toronto, Ontario · founded 2015 · 11 employees$2Mraised▾
Provider of medical cannabis
- Dec 2018Seed$2M
#9
Seed · Windsor, Ontario · founded 2013 · 4 employees$2.6Mraised▾
Holding company focused on hemp based healthcare services & products
- Mar 2016Conventional Debt—
- Mar 2016Seed$2.6M
#10
Acquired · Markham, Ontario · founded 2004 · 350 employees$75.3Kraised▾
Everest Clinical Research is a full-service CRO providing clinical research services to life science industries. It offers services such as biostatistics & statistical programming, interactive response technologies, pharmacovigilance, regulatory submissions, clinical data management, clinical operations, medical & scientific writing and data monitoring services. It uses the various platform to perform these functions, for example, uses Inform, Rave, iDataFax for electronic data capture and WinNonlin for PK&PD analysis.
- Aug 2019Grant (prize money)$75.3K
#11
Seed · Toronto, Ontario · founded 2015 · 19 employees$48.7Kraised▾
Provider of animal healthcare solutions
- Mar 2019Seed$48.7K
#12
Seed · Cambridge, Ontario · founded 2010 · 16 employees—raised▾
Developer of imaging detection capillary isoelectric focusing iCIEF technology intended to serve the biopharma and protein chemistry industries. The company's technology includes whole column imaging detection capillary isoelectric focusing WCID-iCIEF systems, critical reagents customizations for fusion protein, antibody-drug conjugates, and monoclonal antibodies, enabling customers to facilitate antibody, fusion protein, and next generation of biopharma process.
- Jun 2022Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
What Ontario researches in biotechnology
Ontario Institute for Cancer Research and Public Health Ontario lead cautiously optimistic biotechnology research (mean stance 0.47), dominated by nanoplatform cancer theranostics and respiratory health, with concern tempered by recent breakthroughs.
- Ontario Institute for Cancer Research6
- Public Health Ontario2
- Children\'s Hospital of Eastern Ontario2
- Ontario Tech University1
- Ontario Genomics1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.